EndoGastric Solutions Hires Seasoned Chief Financial
Officer and Director of US Sales Experienced in Launching Leading Edge Medical
Technology
Redmond, Washington – April 13, 2007 - EndoGastric Solutions, the world leader
in endoluminal intragastric surgery, is pleased to announce the appointment of
Guy Seaton to the position of Chief Financial Officer and Larry Fulton as Senior
Director of US Sales.
“We are extremely pleased to have Guy and Larry on our team. They are joining us
at the same time we are launching our first product in the United States,” said
Thierry Thaure, President and CEO of EndoGastric Solutions. “Their experience
bringing companies and products from concept to full commercialization will help
us continue to build a strong company from both a product standpoint as well as
strengthen our position as the leader in incisionless surgery.”
With more than 25 years of experience in corporate finance, Mr. Seaton has a
strong track record of bringing companies including InControl Inc., SonoSite
Inc. and Corus Pharma Inc. from venture stage companies to the next level in the
development process.
“EndoGastric Solutions’ technology has the potential to make a dramatic impact
in the marketplace,” said Mr. Seaton. “EsophyX™ has been well received in Europe
and, with StomaphyX™ now cleared in the US, this is an incredible opportunity to
continue the company’s success by iterating the current products while
continuing to develop a full spectrum of products to treat a number of
diseases.”
Leading the US sales team, Mr. Fulton brings over 15 years of experience in
minimally invasive surgery and, most recently, spent seven years in Executive
Sales management roles at Inamed Health/BioEnterics where he was a key player in
bringing the Lap-Band® from clinical trials to mass market.
“From my experience, EGS is on track to continue its success because our
products are revolutionizing the way physicians treat GERD and other diseases,”
said Mr. Fulton. “The response that we have received with the US launch of
StomaphyX has been incredible. Many of the people I have been talking with see a
tremendous opportunity for this product and the technology — something at or
beyond the scale of what laparoscopic surgery was able to accomplish when it was
adopted.”
About EndoGastric Solutions, Inc
EndoGastric Solutions™ is a pioneer in endoluminal procedures for the treatment
of gastrointestinal diseases, including GERD and obesity. EndoGastric Solutions’
mission is to utilize the most current wisdom in gastroenterology and surgery to
develop new transoral procedures and products to address the largest unmet needs
in gastrointestinal diseases. EndoGastric Solutions technologies involve
modifying current open surgical and/or laparoscopic approaches by using
transoral access instead of abdominal incisions. The company designs and
manufactures single-use instruments that will enable these incisionless
solutions, and focuses on clinically based products for use by
gastroenterologists and surgeons.
StomaphyX is available in the United States. EsophyX is not available for sale
or use in the United States. Both devices are CE marked and available in the
European Union.
For more information about EndoGastric Solutions, Inc., EsophyX and StomaphyX
please visit:
Contact Information US Customer Contact:
Larry K Fulton
Senior Director of U.S. Sales
EndoGastric Solutions, Inc.
760-994-3355
lfulton@endogastricsolutions.com
European Customer Contact:
Joan McLoughlin
Vice President Education
+32-487-175-933
jmcloughlin@endogastricsolutions.com
Press Contact:
Jason Thompson
Marketing Communications Manager
206-218-5982
jthompson@endogastricsolutions.com
Investor Relations:
Kimberley Lorean
Business Development Manager
425-214-6735
klorean@endogastricsolutions.com
